ClinicalTrials.Veeva

Menu
M

MedPharmics, LLC | Gulfport, MS

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Orforglipron
Galcanezumab
NVX-Cov2373
LY3502970

Parent organization

This site is a part of MedPharmics, LLC

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 18 total trials

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) (ADVANCE)

The purpose of this pediatric, chronic weight management, Phase 3 Master Protocol (PWMP) is to create a framework to evaluate the safety and efficacy...

Not yet enrolling
Overweight
Obesity
Drug: Orforglipron
Drug: Placebo

The main purpose of this study, performed under Master Protocol J4M-MC-PWMP, is to evaluate the efficacy, safety, and pharmacokinetics of orforglipro...

Not yet enrolling
Overweight
Obesity
Drug: Orforglipron
Drug: Placebo

The main purpose of this study is to evaluate the efficacy of mRNA 1647 vaccine in CMV-seronegative female participants and to evaluate the safety an...

Active, not recruiting
Cytomegalovirus Infection
Biological: mRNA-1647
Biological: Placebo

Trial sponsors

Pfizer logo
BioNTech logo
Lilly logo
Abbott logo
Abbott logo
F
Janssen (J&J Innovative Medicine) logo
Moderna logo
Novavax logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems